Viewing StudyNCT05096390



Ignite Creation Date: 2024-05-06 @ 4:47 PM
Last Modification Date: 2024-10-26 @ 2:16 PM
Study NCT ID: NCT05096390
Status: RECRUITING
Last Update Posted: 2024-01-25
First Post: 2021-10-14

Brief Title: Axitinib - Pembrolizumab in First Line Treatment of mPRCC
Sponsor: Centre Leon Berard
Organization: Centre Leon Berard

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-06-01
Start Date Type: ACTUAL
Primary Completion Date: 2024-10
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-06
Completion Date Type: ESTIMATED
First Submit Date: 2021-10-14
First Submit QC Date: October 14 2021
Study First Post Date: 2021-10-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-24
Last Update Post Date: 2024-01-25
Last Update Post Date Type: ACTUAL